Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke

Journal of Neurology

Volumn 259, Issue 10, 2012, Pages 2053-2059

  Xiao, Dongfang ^a   Liu, Hailong ^a   Zhang, Hong ^a   Luo, Yumin ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral stroke; Cystatin C; Hemorrhage volume; Infarct size

Indexed keywords

CHOLESTEROL; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SIZE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

BIOLOGICAL MARKERS; CEREBRAL INFARCTION; CYSTATIN C; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84867334485     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6453-2     Document Type: Article

References (41)

1. Aguilar MI, O'Meara ES, Seliger S, Longstreth WT Jr, Hart RG, Pergola PE, Shlipak MG, Katz R, Sarnak MJ, Rifkin DE (2010) Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology 75:1343-1350
2. Arboix A, Miguel M, Ciscar E, Garcia-Eroles L, Massons J, Balcells M (2006) Cardiovascular risk factors in patients aged 85 or older with ischemic stroke. Clin Neurol Neurosurg 108:638-643
3. Arpegård J, Ostergren J, de Faire U, Hansson LO, Svensson P (2008) Cystatin C-a marker of peripheral atherosclerotic disease? Atherosclerosis 199:397-401
4. Barrett AJ, Fritz H, Grubb A, Isemura S, Järvinen M, Katunuma N, Machleidt W, Müller-Esterl W, Sasaki M, Turk V (1986) Nomenclature and classification of the proteins homologous with the cysteine-roteinase inhibitor chicken cystatin. Biochem J 236:312
5. Bui AL, Katz R, Kestenbaum B, de Boer IH, Fried LF, Polak JF, Wasserman BA, Sarnak MJ, Siscovick D, Shlipak MG (2009) Cystatin C and carotid intima-media thickness in asymptomatic adults: the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis 53:389-398
6. Chew JS, Saleem M, Florkowski CM, George PM (2008) Cystatin C-a paradigm of evidence based laboratory medicine. Clin Biochem Rev 29:47-62
7. Coll E, Botey A, Alvarez L, Poch E, Quintó L, Saurina A, Vera M, Piera C, Darnell A (2000) Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36:29-34
8. Devos A, De Clercq N, Vercaeren I, Heyns W, Rombauts W, Peeters B (1993) Structure of rat genes encoding androgen-regulated cystatin-related proteins (CRPs): a new member of the cystatin superfamily. Gene 125:159-167
9. Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221-226
10. Eriksson P, Deguchi H, Samnegård A, Lundman P, Boquist S, Tornvall P, Ericsson CG, Bergstrand L, Hansson LO, Ye S, Hamsten A (2004) Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 24:551-557
11. Ferraro S, Marano G, Biganzoli EM, Boracchi P, Bongo AS (2011) Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target. Clin Chem Lab Med 49:1397-1404
12. Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez- Brú C, Grubb A (2005) Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38:1-8
13. Fliser D, Ritz E (2001) Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 37:79-83
14. Grubb A, Björk J, Lindström V, Sterner G, Bondesson P, Nyman U (2005) A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 65:153-162
15. Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J (2009) Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods 177:469-478
16. Hoke M, Amighi J, Mlekusch W, Schlager O, Exner M, Sabeti S, Dick P, Koppensteiner R, Minar E, Rumpold H, Wagner O, Schillinger M (2010) Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke 41:674-679
17. Huang Q, Hong B, Xu Y, Liu J (2009) Very late thrombosis in a patient with a drug-eluting stent for intracranial atherosclerotic stenosis. J Clin Neurosci 16:1631-1633
18. Huang WY, Chen IC, Meng L, Weng WC, Peng TI (2009) The influence of anemia on clinical presentation and outcome of patients with first-ever atherosclerosis-related ischemic stroke. J Clin Neurosci 16:645-649
19. Ishimura E, Shoji T, Emoto M, Motoyama K, Shinohara K, Matsumoto N, Taniwaki H, Inaba M, Nishizawa Y (2001) Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus. Am J Kidney Dis 38:S186-S190
20. Koenig W, Twardella D, Brenner H, Rothenbacher D (2005) Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51:321-327
21. Laterza OF, Price CP, Scott MG (2002) Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 48:699-707
22. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, Tomolillo C, Del Sette M, Bezante GP, Deferrari G, Pontremoli R (2003) Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 42:14-18
23. Levey AS (1990) Measurement of renal-function in chronic renal-disease. Kidney Int 38:167-184
24. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24:1359-1366
25. Newman DJ (2002) Cystatin C. Ann Clin Biochem 39:89-104
26. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP (1995) Serum cystatin C measured by automated immunoassay-a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47:312-318
27. Ni L, Lü J, Hou LB, Yan JT, Fan Q, Hui R, Cianflone K, Wang W, Wang DW (2007) Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke 38:3287-3288
28. Oksala NKJ, Salonen T, Strandberg T, Oksala A, Pohjasvaara T, Kaste M, Karhunen PJ, Erkinjuntti T (2010) Cerebral small vessel disease and kidney function predict long-term survival in patients with acute stroke. Stroke 41:1914-1920
29. Petrica L, Petrica M, Gheorghe G, Liviu M, Florica G, Sorin U, Catalin J, Silvia V, Flaviu B, Cristina G, Virginia T, Diana M, Gheorghe B, Carmina M (2010) Does chronic kidney disease define a particular risk pattern of cerebral vessels modifications in patients with symptomatic ischemic cerebrovascular disease? Cent Eur J Med 5:329-337
30. Rawlings ND, Barrett AJ (1990) Evolution of proteins of the cystatin superfamily. J Mol Evol 30:60-71
31. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141:929-937
32. Seliger SL, Gillen DL, Longstreth WT, Kestenbaum B, Stehman-Breen CO (2003) Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64:603-609
33. Seliger SL, Longstreth WT, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, Bleyer A, Siscovick DS (2005) Cystatin C and subclinical brain infarction. J Am Soc Nephrol 16:3721-3727
34. Sharifkazemi MB, Aslani A, Zamirian M, Moaref AR (2007) Significance of aortic atheroma in elderly patients with ischemic stroke-a hospital-based study and literature review. Clin Neurol Neurosurg 109:311-316
35. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104:1191-1197
36. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237-246
37. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352:2049-2060
38. Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354:2473-2483
39. Tang WHW, Van Lente F, Shrestha K, Troughton RW, Francis GS, Tong W, Martin MG, Borowski AG, Jasper S, Starling RC, Klein AL (2008) Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Cardiac Fail 14:394-399
40. Urbonaviciene G, Shi GP, Urbonavicius S, Henneberg EW, Lindholt JS (2011) Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis 216:440-445
41. Yokokawa H, Goto A, Terui K, Funami Y, Watanabe K, Yasumura S (2008) Prevalence of metabolic syndrome and serum marker levels in patients with four subtypes of cerebral infarction in Japan. J Clin Neurosci 15:769-773